Navigation Links
John Theurer Cancer Center to host inaugural Mantle Cell Lymphoma Symposium
Date:11/7/2011

HACKENSACK, N.J. (November XX, 2011) The Lymphoma Division of the John Theurer Cancer Center at Hackensack University Medical Center with the participation from the Facebook groups "Hope for Lymphoma" and "Our MCL Family," will host its first-ever Mantle Cell Lymphoma Symposium on Saturday, November 12 from 8:30am 3:45pm. The event is open to both healthcare professionals and also to Mantle Cell Lymphoma (MCL) patients and their caregivers coping with this challenging diagnosis.

The complimentary Continuing Medical Education (CME) program will feature an international faculty of leading MCL experts who will review the latest advances in research, state-of-the-art- treatment options for new and relapsed disease and new and novel therapies for MCL.

MCL is a B-cell blood cancer called so because tumors are composed of cells that come from the "mantle" zone of the lymph node. It is one of the rarest and most challenging to treat of the non-Hodgkin's lymphomas (NHLs), comprising about 6% of NHL cases and currently affects about 15,000 patients in the U.S.

"MCL research has advanced the treatment options available and doubled the life expectancy for patients with this disease, but there is still much more work to be done," said Andre Goy, M.D., M.S., Chairman and Director and Chief of Lymphoma, John Theurer Cancer Center. "We can continue to develop better treatment options by collaborating with our patients. This will help them better understand and manage their disease to help move our clinical research forward."

A leading MCL researcher, member of the prestigious Mantle Cell Consortium and a member of the Lymphoma Research Foundation's esteemed Scientific Advisory Board, Dr. Goy was the Principal Investigator on the pivotal PINNACLE study, which led to the approval of the drug VELCADE, a treatment for relapsed MCL.

"Our group is honored to collaborate with Dr. Goy and the John Theurer Cancer Center to help prov
'/>"/>

Contact: Amy Leahing
amy.leahing@zibbel.com
305-458-0599
John Theurer Cancer Center
Source:Eurekalert

Page: 1 2 3

Related medicine news :

1. John Theurer Cancer Center hosts New Frontiers in the Management of Solid and Liquid Tumors
2. John Theurer Cancer Center among first clinical trial sites to join landmark MMRF study
3. Lymphoma Research Foundation and John Theurer Cancer Center collaborate for Lymphoma Rounds program
4. John Theurer Cancer Center and the Promise Foundation partner to offer free skin cancer screenings
5. The John Theurer Cancer Center to host Seventh Annual Neuro-Oncology Symposium
6. John Theurer Cancer Center first in New Jersey to offer complete capabilities of Provenge
7. The MMRF and John Theurer Cancer Center to host patient symposium
8. John Theurer Cancer Center orthopedic oncologist shares new limb sparing surgical techniques
9. John Theurer Cancer Center to host Eighth Annual Northern New Jersey Breast Cancer Conference
10. Oncology basic research director at John Theurer Cancer Center continues transplantation research
11. John Theurer Cancer Center presents studies on promising therapies for aggressive blood cancers
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/28/2015)... 28, 2015 Designers and Professionals of ... entitled Scratches 5K from Pixel Film Studios. , “Scratches ... any media inside Final Cut Pro X” Said Christina ... time and is an effective tool for any FCPX ... Scratches 5K's intuitive grunge overlays. Simply drag title layers ...
(Date:3/28/2015)... CA (PRWEB) March 28, 2015 ... specialists , this week released a report about the ... symptoms of asthma sufferers, and according to recent medical ... , According to the Environmental Protection Agency, people ... asthmatic reactions. Breathing in mold may trigger asthma attacks ...
(Date:3/27/2015)... Island, NY (PRWEB) March 27, 2015 ... cancer-focused training and business criteria for the spa and ... services to clients who have experienced or are living ... the global Spafinder Wellness 365® Network, will be identified ... and recognized as a provider of safe, therapeutic services ...
(Date:3/27/2015)... The federal court overseeing thousands of ... medication increases the risk that a patient will develop ... Dismiss four individual cases that had been filed in ... in the U.S. District Court, District of South Carolina, ... were warranted because the plaintiffs in those claims had ...
(Date:3/27/2015)... March 27, 2015 Top medical tourism ... patients travel to the Dominican Republic to benefit from ... clinic is turning the medical tourism industry upside-down and ... — with trustworthy services becoming the central influence. ... plastic surgeon. Patients are not only attracted to low-cost ...
Breaking Medicine News(10 mins):Health News:Pixel Film Studios Unveiled Scratches 5k for Final Cut Pro X Editors 2Health News:Water Damage Restoration Specialists Servpro of Paso Robles Release Report on Mold and Asthma 2Health News:Water Damage Restoration Specialists Servpro of Paso Robles Release Report on Mold and Asthma 3Health News:Hands On HealthCare Massage Therapy & Wellness Day Spa Certified as “Cancer Aware” by Wellness for Cancer and Recognized on Spafinder.com 2Health News:Hands On HealthCare Massage Therapy & Wellness Day Spa Certified as “Cancer Aware” by Wellness for Cancer and Recognized on Spafinder.com 3Health News:Hands On HealthCare Massage Therapy & Wellness Day Spa Certified as “Cancer Aware” by Wellness for Cancer and Recognized on Spafinder.com 4Health News:Lipitor Lawsuits Move Forward in Federal Multidistrict Litigation, as Court Rules on Pfizer’s Motion to Dismiss Certain Cases 2Health News:Lipitor Lawsuits Move Forward in Federal Multidistrict Litigation, as Court Rules on Pfizer’s Motion to Dismiss Certain Cases 3Health News:Dominican Republic Plastic Surgery Provider Turning Medical Tourism Upside-Down 2Health News:Dominican Republic Plastic Surgery Provider Turning Medical Tourism Upside-Down 3
... many as 178 newborn babies died at a government-run ... Amar Agrawal told the state assembly Tuesday . ... about the lack of basic medical facilities at the ... reported 424 deaths of newly born babies in 2006 ...
... bird flu antibodies in migrant birds in five Siberian regions, ... ,"Out of over 4,000 samples taken in the ... to contain genetic material of the A-H5 virus and antibodies ... spokesman said the presence of antibodies meant that either the ...
... two studies indicate that elevated nonfasting triglyceride levels ... heart attack , with one study finding that ... this association. ,Triglyceride levels are usually ... certain types of lipoprotein particles (remnant lipoproteins), a ...
... patients a short course of corticosteroids after they have been ... of a relapse, a Cochrane Systematic Review has found. ... benefit lasts for about three weeks. ,This updated ... together involved 374 people. ,,Between 12% and 16% of ...
... is a more effective way of losing weight after pregnancy ... during pregnancy and many gradually lose it afterwards, but some ... retained body weight may be one factor that contributes to ... of returning to, and maintaining, pre-pregnant weights, and there is ...
... (saline) into your nose can help reduce the symptoms ... of the nasal passages. , ,Between 5% and ... passages (chronic rhinosinusitis). Many homoeopathic and yogic forms of ... symptoms, and it is now often recommended as part ...
Cached Medicine News:Health News:High Nonfasting Triglyceride Levels Linked With Cardiovascular Risks 2
(Date:3/27/2015)... According to a new market research report ... Ablation Catheter (Cryoablation, RF, Microwave), Lab Devices (Mapping, Recording, ... Global Forecasts to 2019 ", published by MarketsandMarkets, the Electrophysiology ... by 2019 with a CAGR of around 10.3% during ... Browse   90   ma rket data T ...
(Date:3/27/2015)... 2015   Hospira, Inc. (NYSE: ... the world,s leading provider of injectable drugs and ... evaluation of biosimilarity of its proposed biosimilar, Epoetin ... (FDA) conditionally approved name of RETACRIT™, compared to ... study data were presented at the National Kidney ...
(Date:3/27/2015)... , March 27, 2015 ... 2015" therapeutic market research report of 52 pages ... online business intelligence library. The report ... on the therapeutic development for Visceral Pain, complete ... by drug target, mechanism of action (MoA), route ...
Breaking Medicine Technology:Electrophysiology (EP) Market Worth $4.73 Billion by 2019 2Electrophysiology (EP) Market Worth $4.73 Billion by 2019 3Electrophysiology (EP) Market Worth $4.73 Billion by 2019 4Hospira Clinical Data Shows Proposed Biosimilar, Epoetin Hospira, Demonstrates Pharmacokinetic And Pharmacodynamic Equivalence Compared To Amgen's Epogen 2Hospira Clinical Data Shows Proposed Biosimilar, Epoetin Hospira, Demonstrates Pharmacokinetic And Pharmacodynamic Equivalence Compared To Amgen's Epogen 3Visceral Pain Pipeline Review H1 2015 Market Research Report 2Visceral Pain Pipeline Review H1 2015 Market Research Report 3Visceral Pain Pipeline Review H1 2015 Market Research Report 4
... a world-leading developer and marketer of innovative medical technologies ... Ltd, a wholly-owned subsidiary of ConvaTec Holdings UK Ltd, ... a UK-based company that specialises in the discreet home ... As a well-respected company in the home ...
... President and CEO Randall Moreadith, MD, PhD, reported today that ... advance its lead oncology candidate SER-203 into a Phase I ... pleased to report to our existing and new shareholders the ... 2010. This is a very significant milestone for Serina Therapeutics, ...
Cached Medicine Technology:ConvaTec Announces Acquisition of Trent Direct 2Serina Therapeutics, Inc. Closes $9.5 Million Financing Round 2
1.0% Casein digest (NZ amine), 0.5% Sodium Chloride, 0.5% Yeast Extract, 1.0% bacto casamino acids, 0.2% Mag. Sulfate....
0.5% Yeast Extract, 2.0% Tryp, 10mM Sodium Chloride, 2.5mM Potassium Chloride, 10mM Magnesium Chloride, 10mM Mag. Sulfate....
Innovative hemi device combining anatomic design with the advanced material pyrocarbon....
3.2% Tryptone, 2.0% Yeast Extract, 0.5% Sodium Chloride, pH 7.5....
Medicine Products: